News & Updates

Low-intensity focused ultrasound can be delivered to the target zone in patients with drug-resistant epilepsy without significant adverse events, as shown in a phase I study. Moreover, the treatment produces meaningful changes in stereo-electroencephalography activity.

In the treatment of adults with uncontrolled focal seizures, the long-term, open-label use of cenobamate appears to produce high rates of sustained 100-percent and ≥90-percent seizure reduction, with parallel decreases in concomitant antiseizure medication (ASM) doses, according to two separate post hoc analyses of a phase III C021 trial.